SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway (vol 39, 79, 2020)

被引：0

作者：

Zhang, Jing ^{[1
]}

Liu, Xiao-han ^{[1
]}

Li, Cong ^{[1
]}

Wu, Xiao-xing ^{[2
]}

Chen, Yan-lin ^{[3
]}

Li, Wen-wen ^{[4
]}

Li, Xian ^{[4
]}

Gong, Fan ^{[1
]}

Tang, Qin ^{[1
]}

Jiang, Dan ^{[1
]}

机构：

[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Chongqing 400016, Peoples R China

[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing 400016, Peoples R China

[3] Chongqing Med Univ, Affiliated Hosp 1, Jinshan Hosp, Dept Pathol, Chongqing 401122, Peoples R China

[4] Chongqing Med Univ, Fac Basic Med, Dept Pathol, Chongqing 400016, Peoples R China

来源：

基金：

中国国家自然科学基金;

关键词：

High-grade serous ovarian cancer; Metastasis PI3K/Akt; Progression; SNCG;

D O I：

10.1186/s13046-020-01596-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

An amendment to this paper has been published and can be accessed via the original article.

引用

页数：3